A consensus statement urges the adoption of enhanced radiation protection devices to reduce occupational risks for health care workers.
Insurance Asia on MSN
China cuts medical device prices under national crackdown
More than 50,000 certified workers have been trained to deliver nursing and personal assistance. China's basic medical ...
Setting a new standard for carotid artery stenting in high-risk patients. Stroke remains one of the leading causes of death and long-term disability worldwide, with carotid artery disease causing ...
The trial will generate critical clinical evidence and discovery for the novel medical device. The CAPTURE-2 trial is designed to assess the safety and performance of the EmStop embolic protection ...
NEW ORLEANS — The first embolic protection device designed to prevent periprocedural debris from entering any of the three cerebral vessels or the descending aorta during transcatheter aortic valve ...
In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter aortic valve replacement (TAVR), the investigational Emboliner device ...
Emboline is one step closer to the commercialization of its Emboliner Embolic Protection System. The Santa Cruz, CA-based company presented positive results from the pivotal PROTECT H2H global ...
For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are ...
SANTA CRUZ, Calif., March 11, 2026 /PRNewswire/ -- Emboline, Inc., a privately held medical technology company focused on reducing stroke and ischemic damage during structural heart procedures such as ...
The initiative targets FXIa inhibition to prevent harmful clots while preserving healthy clotting, addressing current therapy limitations. Cardiovascular and thromboembolic diseases remain leading ...
InspireMD Inc (NSPR) announced an update on their ongoing clinical study. InspireMD Inc. has announced a pivotal clinical study titled ‘CGUARDIANS III IDE Pivotal Trial.’ This study aims to evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results